LAMP1 and COVID-19: In contrast, our findings are consistent with recent work by Bert M. et al (Malengier-Devlies et al., 2022), who similarly reported upregulation of both IFN-γ and LAMP1 in peripheral blood NK cells from patients with severe COVID-19.